Operation for ventricular tachyarrhythmias: Refining current treatment strategies

James J. Morris, Amita Rastogi, Marshall S. Stanton, Bernard J. Gersh, Stephen C. Hammill, Hartzell V Schaff

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

For many patients with ventricular tachyarrhythmias, the optimal choice of palliative or curative therapies is not yet well established. To refine optimal current treatment strategies, baseline patient characteristics were studied in relation to likelihood of successful outcome in 240 consecutive patients undergoing operation for treatment of ventricular tachyarrhythmias from 1981 to 1991. Indications for operation were sudden cardiac death or inducible ventricular tachyarrhythmias refractory to medical therapy (or both). Treatment was directed endocardial procedures in 77 patients (32%), other cardiac procedures in 57 patients (24%) (coronary artery bypass grafting in 94% and valve procedure in 14%, either with [35%] or without [65%] concomitant implantable cardioverter-defibrillator), and implantable cardioverter-defibrillator alone in 106 patients (44%). Overall 30-day operative mortality was 5% (70% confidence interval, 4%-7%) and 2-year survival was 74% (70% confidence interval, 71%-77%). Overall 2-year freedom from sudden cardiac death was 97% (70% confidence interval, 96%-98%) and was similar (p = not significant) for all treatment modalities. For each treatment modality, multivariate analysis identified independent risk factors for operative mortality and 2-year tachyarrhythmia recurrence, advanced angina and congestive heart failure New York Heart Association classes, and overall mortality. To characterize better the use and benefit of coronary artery bypass grafting, risk factors related to outcome also were identified for patients stratified according to absence (44 patients) or presence (119 patients) of coronary artery disease excluding patients treated by directed endocardial procedures. In non-coronary artery disease patients, operative mortality was 0%. In coronary artery disease patients, operative mortality was 6% (70% confidence interval 3%-9%) in 65 patients treated with implantable cardioverter defibrillator only, 3% (70% confidence interval, 0%-5%) in 37 patients treated with coronary artery bypass grafting, and 0% in 17 patients treated with implantable cardioverter-defibrillator and coronary artery bypass grafting. Criteria which discriminated coronary artery disease patients treated and not treated by coronary artery bypass grafting were identified. Based on these observations, a refinement of optimal treatment strategies is presented. Whereas all surgical therapies for ventricular tachyarrhythmia convey similar benefits in reducing sudden cardiac death in appropriately selected patients, overall successful outcome is highly dependent on effective treatment of coexistent cardiac disease, in particular, coronary artery disease.

Original languageEnglish (US)
Pages (from-to)1490-1498
Number of pages9
JournalThe Annals of Thoracic Surgery
Volume58
Issue number5
DOIs
StatePublished - 1994

Fingerprint

Tachycardia
Coronary Artery Bypass
Implantable Defibrillators
Therapeutics
Confidence Intervals
Coronary Artery Disease
Sudden Cardiac Death
Mortality
Heart Diseases

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Operation for ventricular tachyarrhythmias : Refining current treatment strategies. / Morris, James J.; Rastogi, Amita; Stanton, Marshall S.; Gersh, Bernard J.; Hammill, Stephen C.; Schaff, Hartzell V.

In: The Annals of Thoracic Surgery, Vol. 58, No. 5, 1994, p. 1490-1498.

Research output: Contribution to journalArticle

Morris, James J. ; Rastogi, Amita ; Stanton, Marshall S. ; Gersh, Bernard J. ; Hammill, Stephen C. ; Schaff, Hartzell V. / Operation for ventricular tachyarrhythmias : Refining current treatment strategies. In: The Annals of Thoracic Surgery. 1994 ; Vol. 58, No. 5. pp. 1490-1498.
@article{bd8b43f1aeb54dea88ff05d9e451d338,
title = "Operation for ventricular tachyarrhythmias: Refining current treatment strategies",
abstract = "For many patients with ventricular tachyarrhythmias, the optimal choice of palliative or curative therapies is not yet well established. To refine optimal current treatment strategies, baseline patient characteristics were studied in relation to likelihood of successful outcome in 240 consecutive patients undergoing operation for treatment of ventricular tachyarrhythmias from 1981 to 1991. Indications for operation were sudden cardiac death or inducible ventricular tachyarrhythmias refractory to medical therapy (or both). Treatment was directed endocardial procedures in 77 patients (32{\%}), other cardiac procedures in 57 patients (24{\%}) (coronary artery bypass grafting in 94{\%} and valve procedure in 14{\%}, either with [35{\%}] or without [65{\%}] concomitant implantable cardioverter-defibrillator), and implantable cardioverter-defibrillator alone in 106 patients (44{\%}). Overall 30-day operative mortality was 5{\%} (70{\%} confidence interval, 4{\%}-7{\%}) and 2-year survival was 74{\%} (70{\%} confidence interval, 71{\%}-77{\%}). Overall 2-year freedom from sudden cardiac death was 97{\%} (70{\%} confidence interval, 96{\%}-98{\%}) and was similar (p = not significant) for all treatment modalities. For each treatment modality, multivariate analysis identified independent risk factors for operative mortality and 2-year tachyarrhythmia recurrence, advanced angina and congestive heart failure New York Heart Association classes, and overall mortality. To characterize better the use and benefit of coronary artery bypass grafting, risk factors related to outcome also were identified for patients stratified according to absence (44 patients) or presence (119 patients) of coronary artery disease excluding patients treated by directed endocardial procedures. In non-coronary artery disease patients, operative mortality was 0{\%}. In coronary artery disease patients, operative mortality was 6{\%} (70{\%} confidence interval 3{\%}-9{\%}) in 65 patients treated with implantable cardioverter defibrillator only, 3{\%} (70{\%} confidence interval, 0{\%}-5{\%}) in 37 patients treated with coronary artery bypass grafting, and 0{\%} in 17 patients treated with implantable cardioverter-defibrillator and coronary artery bypass grafting. Criteria which discriminated coronary artery disease patients treated and not treated by coronary artery bypass grafting were identified. Based on these observations, a refinement of optimal treatment strategies is presented. Whereas all surgical therapies for ventricular tachyarrhythmia convey similar benefits in reducing sudden cardiac death in appropriately selected patients, overall successful outcome is highly dependent on effective treatment of coexistent cardiac disease, in particular, coronary artery disease.",
author = "Morris, {James J.} and Amita Rastogi and Stanton, {Marshall S.} and Gersh, {Bernard J.} and Hammill, {Stephen C.} and Schaff, {Hartzell V}",
year = "1994",
doi = "10.1016/0003-4975(94)91942-9",
language = "English (US)",
volume = "58",
pages = "1490--1498",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Operation for ventricular tachyarrhythmias

T2 - Refining current treatment strategies

AU - Morris, James J.

AU - Rastogi, Amita

AU - Stanton, Marshall S.

AU - Gersh, Bernard J.

AU - Hammill, Stephen C.

AU - Schaff, Hartzell V

PY - 1994

Y1 - 1994

N2 - For many patients with ventricular tachyarrhythmias, the optimal choice of palliative or curative therapies is not yet well established. To refine optimal current treatment strategies, baseline patient characteristics were studied in relation to likelihood of successful outcome in 240 consecutive patients undergoing operation for treatment of ventricular tachyarrhythmias from 1981 to 1991. Indications for operation were sudden cardiac death or inducible ventricular tachyarrhythmias refractory to medical therapy (or both). Treatment was directed endocardial procedures in 77 patients (32%), other cardiac procedures in 57 patients (24%) (coronary artery bypass grafting in 94% and valve procedure in 14%, either with [35%] or without [65%] concomitant implantable cardioverter-defibrillator), and implantable cardioverter-defibrillator alone in 106 patients (44%). Overall 30-day operative mortality was 5% (70% confidence interval, 4%-7%) and 2-year survival was 74% (70% confidence interval, 71%-77%). Overall 2-year freedom from sudden cardiac death was 97% (70% confidence interval, 96%-98%) and was similar (p = not significant) for all treatment modalities. For each treatment modality, multivariate analysis identified independent risk factors for operative mortality and 2-year tachyarrhythmia recurrence, advanced angina and congestive heart failure New York Heart Association classes, and overall mortality. To characterize better the use and benefit of coronary artery bypass grafting, risk factors related to outcome also were identified for patients stratified according to absence (44 patients) or presence (119 patients) of coronary artery disease excluding patients treated by directed endocardial procedures. In non-coronary artery disease patients, operative mortality was 0%. In coronary artery disease patients, operative mortality was 6% (70% confidence interval 3%-9%) in 65 patients treated with implantable cardioverter defibrillator only, 3% (70% confidence interval, 0%-5%) in 37 patients treated with coronary artery bypass grafting, and 0% in 17 patients treated with implantable cardioverter-defibrillator and coronary artery bypass grafting. Criteria which discriminated coronary artery disease patients treated and not treated by coronary artery bypass grafting were identified. Based on these observations, a refinement of optimal treatment strategies is presented. Whereas all surgical therapies for ventricular tachyarrhythmia convey similar benefits in reducing sudden cardiac death in appropriately selected patients, overall successful outcome is highly dependent on effective treatment of coexistent cardiac disease, in particular, coronary artery disease.

AB - For many patients with ventricular tachyarrhythmias, the optimal choice of palliative or curative therapies is not yet well established. To refine optimal current treatment strategies, baseline patient characteristics were studied in relation to likelihood of successful outcome in 240 consecutive patients undergoing operation for treatment of ventricular tachyarrhythmias from 1981 to 1991. Indications for operation were sudden cardiac death or inducible ventricular tachyarrhythmias refractory to medical therapy (or both). Treatment was directed endocardial procedures in 77 patients (32%), other cardiac procedures in 57 patients (24%) (coronary artery bypass grafting in 94% and valve procedure in 14%, either with [35%] or without [65%] concomitant implantable cardioverter-defibrillator), and implantable cardioverter-defibrillator alone in 106 patients (44%). Overall 30-day operative mortality was 5% (70% confidence interval, 4%-7%) and 2-year survival was 74% (70% confidence interval, 71%-77%). Overall 2-year freedom from sudden cardiac death was 97% (70% confidence interval, 96%-98%) and was similar (p = not significant) for all treatment modalities. For each treatment modality, multivariate analysis identified independent risk factors for operative mortality and 2-year tachyarrhythmia recurrence, advanced angina and congestive heart failure New York Heart Association classes, and overall mortality. To characterize better the use and benefit of coronary artery bypass grafting, risk factors related to outcome also were identified for patients stratified according to absence (44 patients) or presence (119 patients) of coronary artery disease excluding patients treated by directed endocardial procedures. In non-coronary artery disease patients, operative mortality was 0%. In coronary artery disease patients, operative mortality was 6% (70% confidence interval 3%-9%) in 65 patients treated with implantable cardioverter defibrillator only, 3% (70% confidence interval, 0%-5%) in 37 patients treated with coronary artery bypass grafting, and 0% in 17 patients treated with implantable cardioverter-defibrillator and coronary artery bypass grafting. Criteria which discriminated coronary artery disease patients treated and not treated by coronary artery bypass grafting were identified. Based on these observations, a refinement of optimal treatment strategies is presented. Whereas all surgical therapies for ventricular tachyarrhythmia convey similar benefits in reducing sudden cardiac death in appropriately selected patients, overall successful outcome is highly dependent on effective treatment of coexistent cardiac disease, in particular, coronary artery disease.

UR - http://www.scopus.com/inward/record.url?scp=0027988441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027988441&partnerID=8YFLogxK

U2 - 10.1016/0003-4975(94)91942-9

DO - 10.1016/0003-4975(94)91942-9

M3 - Article

C2 - 7979681

AN - SCOPUS:0027988441

VL - 58

SP - 1490

EP - 1498

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 5

ER -